CORT Quote, Trading Chart, Corcept Therapeutics Incorporated
home / stock / cort / cort quote
$22.67 Last:
1.84% Change Percent:
$22.4 Open:
$22.67 Previous Close:
$22.87 High:
$22.275 Low:
628,599 Volume:
06/24/2021 04:41:42 am Last Trade Date Time:
Quotes are delayed by 15 to 20 minutes.
CORT Last Five Trading Days
| Stock Date | Open Price | Close Price | High | Low | Volume |
|---|---|---|---|---|---|
| 2021-06-24 | 22.4 | 22.67 | 22.87 | 22.275 | 628,599 |
| 2021-06-23 | 22.04 | 22.26 | 22.48 | 21.71 | 654,252 |
| 2021-06-22 | 21.25 | 21.96 | 22.12 | 21.01 | 1,467,281 |
| 2021-06-21 | 22.6 | 22.98 | 23.14 | 22.4 | 611,339 |
| 2021-06-18 | 22.62 | 22.5 | 22.83 | 22.15 | 1,318,628 |
| 2021-06-17 | 22.95 | 22.99 | 23.08 | 22.5 | 567,715 |
| 2021-06-16 | 22.77 | 22.82 | 23.4931 | 22.585 | 988,060 |
| 2021-06-15 | 21.65 | 21.93 | 21.93 | 21.33 | 956,554 |
| 2021-06-14 | 21.69 | 21.58 | 21.69 | 21.48 | 432,121 |
| 2021-06-11 | 21.66 | 21.53 | 21.66 | 21.41 | 439,390 |
| 2021-06-10 | 21.91 | 21.52 | 22.07 | 21.5 | 342,334 |
| 2021-06-09 | 21.68 | 21.89 | 22.39 | 21.51 | 458,496 |
| 2021-06-08 | 21.59 | 21.52 | 21.61 | 21.32 | 439,177 |
| 2021-06-07 | 21.43 | 21.39 | 21.59 | 21.26 | 487,082 |
| 2021-06-04 | 21.91 | 21.41 | 21.99 | 21.39 | 341,796 |
| 2021-06-03 | 21.33 | 21.74 | 21.83 | 21.31 | 490,023 |
| 2021-06-02 | 21.49 | 21.41 | 21.63 | 21.27 | 673,064 |
| 2021-06-01 | 21.66 | 21.54 | 21.82 | 21.31 | 784,224 |
| 2021-05-31 | 21.72 | 21.6 | 21.95 | 21.55 | 407,015 |
| 2021-05-28 | 21.72 | 21.6 | 21.95 | 21.55 | 407,015 |
Corcept Therapeutics Incorporated Company Name:
CORT Stock Symbol:
NASDAQ Market:
News, Short Squeeze, Breakout and More Instantly...
-
Enrollment stopped in RELIANT trial Antitumor activity observed in heavily pretreated patients with metastatic pancreatic cancer, including those previously treated with nab-paclitaxel; addition of relacorilant to nab-paclitaxel therapy was well-tolerated Phase 3 piv...
-
MENLO PARK, Calif., June 15, 2021 (GLOBE NEWSWIRE) -- Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of drugs to treat severe metabolic, oncologic and psychiatric disorders by modulating the effects of cortisol, today an...
-
MENLO PARK, Calif., June 10, 2021 (GLOBE NEWSWIRE) -- Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of drugs to treat severe metabolic, oncologic and psychiatric disorders by modulating the effects of the stress hormone...